NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) released its quarterly earnings data on Wednesday. NewAmsterdam Pharma had a negative net margin of 3,644.21% and a negative return on equity of 34.05%. NewAmsterdam Pharma Stock Up 1.0%NASDAQ:NAMS traded up $0.29 during mid-day trading on Friday, reaching $27.96. NewAmsterdam Pharma has a 12 month low of $23.05 and a 12 month high of $42.21. Further ReadingReceive News & Ratings for NewAmsterdam Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewAmsterdam Pharma and related companies with MarketBeat.com's FREE daily email newsletter.